<DOC>
	<DOC>NCT00759083</DOC>
	<brief_summary>To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention</brief_summary>
	<brief_title>Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Clinically Documented History of HIT/HITTS Suspicion of HIT/HITTS Bleeding Diathesis Ischemic Stroke Chronic Thrombocytopenia Hematologic Malignancy Contraindication to bivalirudin Pregnant or nursing mothers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>HIT</keyword>
	<keyword>HITTS</keyword>
</DOC>